1,041
Views
28
CrossRef citations to date
0
Altmetric
Research Paper

Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 2165-2177 | Received 01 Apr 2013, Accepted 05 May 2013, Published online: 04 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Sidhartha Chaudhury, Elizabeth H. Duncan, Tanmaya Atre, Sheetij Dutta, Michele D. Spring, Wolfgang W. Leitner & Elke S. Bergmann-Leitner. (2020) Combining immunoprofiling with machine learning to assess the effects of adjuvant formulation on human vaccine-induced immunity. Human Vaccines & Immunotherapeutics 16:2, pages 400-411.
Read now
Michael R. Hollingdale, Martha Sedegah & Keith Limbach. (2017) Development of replication-deficient adenovirus malaria vaccines. Expert Review of Vaccines 16:3, pages 261-271.
Read now
Chao Zhang & Dongming Zhou. (2016) Adenoviral vector-based strategies against infectious disease and cancer. Human Vaccines & Immunotherapeutics 12:8, pages 2064-2074.
Read now
Kazutoyo Miura. (2016) Progress and prospects for blood-stage malaria vaccines. Expert Review of Vaccines 15:6, pages 765-781.
Read now
Małgorzata Anna Marć, Enrique Domínguez-Álvarez & Carlos Gamazo. (2015) Nucleic acid vaccination strategies against infectious diseases. Expert Opinion on Drug Delivery 12:12, pages 1851-1865.
Read now
Martha Sedegah, Michael R Hollingdale, Fouzia Farooq, Harini Ganeshan, Maria Belmonte, Jun Huang, Esteban Abot, Keith Limbach, Ilin Chuang, Cindy Tamminga, Judith E Epstein & Eileen Villasante. (2015) Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming. Human Vaccines & Immunotherapeutics 11:11, pages 2705-2715.
Read now
Kenneth Ugen & David B Weiner. (2013) DNA vaccines onward and upward! 20 years and counting! Highlights of the DNA Vaccines 2012 Meeting. Human Vaccines & Immunotherapeutics 9:10, pages 2038-2040.
Read now

Articles from other publishers (21)

Lauren Pischel, Kavin M Patel, George Goshua & Saad B Omer. (2022) Adenovirus-Based Vaccines and Thrombosis in Pregnancy: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 75:7, pages 1179-1186.
Crossref
Elizabeth Kibwana, Melissa Kapulu & Philip Bejon. 2022.
Marvin J. Sklar, Santina Maiolatesi, Noelle Patterson, Martha Sedegah, Keith Limbach, Nimfa Teneza-Mora, Ilin Chuang, K. Monique Hollis-Perry, Jo Glenna Banania, Ivelese Guzman, Harini Ganeshan, Sharina Reyes, Michael R. Hollingdale, Mimi Wong, Ashley Lindstrom, Anatalio Reyes, Yolanda Alcorta, Lindsey Garver, Kelli Bankard, Arnel Belmonte, Maria Belmonte, Jun Huang, Kalpana Gowda, Sandra Inoue, Rachel Velasco, Elke Bergmann-Leitner, Jack Hutter, Tida Lee, Nehkonti Adams, Sidhartha Chaudhury, Devin Hunt, Cindy Tamminga, Eleanor Berrie, Duncan Bellamy, Mustapha Bittaye, Katie Ewer, Carter Diggs, Lorraine A. Soisson, Alison Lawrie, Adrian Hill, Thomas L. Richie, Eileen Villasante, Judith E. Epstein & Christopher A. Duplessis. (2021) A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults. PLOS ONE 16:9, pages e0256980.
Crossref
Alena Pance. (2020) Diversify and Conquer: The Vaccine Escapism of Plasmodium falciparum. Microorganisms 8:11, pages 1748.
Crossref
Luciana C. Lima, Rodolfo F. Marques, Alba Marina Gimenez, Katia S. Françoso, Eduardo Aliprandini, Tarsila M. Camargo, Anna Caroline C. Aguiar, Dhelio B. Pereira, Laurent Renia, Rogerio Amino & Irene S. Soares. (2020) A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of Plasmodium vivax Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic Plasmodium berghei Parasite. Microorganisms 8:6, pages 916.
Crossref
Nichole D. Salinas, Wai Kwan Tang & Niraj H. Tolia. (2019) Blood-Stage Malaria Parasite Antigens: Structure, Function, and Vaccine Potential. Journal of Molecular Biology 431:21, pages 4259-4280.
Crossref
Matthew B.B. McCall, Peter G. Kremsner & Benjamin Mordmüller. (2018) Correlating efficacy and immunogenicity in malaria vaccine trials. Seminars in Immunology 39, pages 52-64.
Crossref
Dennis Lapuente, Zsolt Ruzsics, Christian Thirion & Matthias Tenbusch. (2018) Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses. Vaccine 36:19, pages 2712-2720.
Crossref
Danielle I. Stanisic, James S. McCarthy & Michael F. Good. (2018) Controlled Human Malaria Infection: Applications, Advances, and Challenges. Infection and Immunity 86:1.
Crossref
Martha Sedegah, Bjoern Peters, Michael R. Hollingdale, Harini D. Ganeshan, Jun Huang, Fouzia Farooq, Maria N. Belmonte, Arnel D. Belmonte, Keith J. Limbach, Carter Diggs, Lorraine Soisson, Ilin Chuang & Eileen D. Villasante. (2016) Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes. PLOS ONE 11:10, pages e0163026.
Crossref
Yan Shen, Jun Wang, Yuxiao Huang, Jiao Liang, Xuewu Liu, Dudu Wu, He Jiang, Ya Zhao & Yinghui Li. (2016) Analysis of the immune response of a new malaria vaccine based on the modification of cryptic epitopes. Parasitology Research 115:5, pages 1907-1913.
Crossref
Jairo Andres Fonseca, Monica Cabrera-Mora, Elena A. Kashentseva, John Paul Villegas, Alejandra Fernandez, Amelia Van Pelt, Igor P. Dmitriev, David T. Curiel & Alberto Moreno. (2016) A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine. PLOS ONE 11:4, pages e0154819.
Crossref
Hildegund C.J. Ertl. 2016. Adenoviral Vectors for Gene Therapy. Adenoviral Vectors for Gene Therapy 551 570 .
Katie J. Ewer, Kailan Sierra-Davidson, Ahmed M. Salman, Joseph J. Illingworth, Simon J. Draper, Sumi Biswas & Adrian V.S. Hill. (2015) Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”. Vaccine 33:52, pages 7444-7451.
Crossref
Stephen L. Hoffman, Johan Vekemans, Thomas L. Richie & Patrick E. Duffy. (2015) The March Toward Malaria Vaccines. American Journal of Preventive Medicine 49:6, pages S319-S333.
Crossref
Stephen L. Hoffman, Johan Vekemans, Thomas L. Richie & Patrick E. Duffy. (2015) The march toward malaria vaccines. Vaccine 33, pages D13-D23.
Crossref
Alberto Moreno & Chester Joyner. (2015) Malaria vaccine clinical trials: what's on the horizon. Current Opinion in Immunology 35, pages 98-106.
Crossref
Susanne H. Hodgson, Katie J. Ewer, Carly M. Bliss, Nick J. Edwards, Thomas Rampling, Nicholas A. Anagnostou, Eoghan de Barra, Tom Havelock, Georgina Bowyer, Ian D. Poulton, Simone de Cassan, Rhea Longley, Joseph J. Illingworth, Alexander D. Douglas, Pooja B. Mange, Katharine A. Collins, Rachel Roberts, Stephen Gerry, Eleanor Berrie, Sarah Moyle, Stefano Colloca, Riccardo Cortese, Robert E. Sinden, Sarah C. Gilbert, Philip Bejon, Alison M. Lawrie, Alfredo Nicosia, Saul N. Faust & Adrian V. S. Hill. (2015) Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals. Journal of Infectious Diseases 211:7, pages 1076-1086.
Crossref
David J. Conway. (2015) Paths to a malaria vaccine illuminated by parasite genomics. Trends in Genetics 31:2, pages 97-107.
Crossref
Benedict R. Halbroth & Simon J. Draper. 2015. 1 49 .
Martha Sedegah, Michael R. Hollingdale, Fouzia Farooq, Harini Ganeshan, Maria Belmonte, Yohan Kim, Bjoern Peters, Alessandro Sette, Jun Huang, Shannon McGrath, Esteban Abot, Keith Limbach, Meng Shi, Lorraine Soisson, Carter Diggs, Ilin Chuang, Cindy Tamminga, Judith E. Epstein, Eileen Villasante & Thomas L. Richie. (2014) Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes. PLoS ONE 9:9, pages e106241.
Crossref